<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>江苏金殳 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-29T23:20:53+08:00</updated>
  <subtitle>致力于仿制药、创新药的研发，核心团队近十几年投身于药理毒理、药学和临床注册研究。公司全体员工以改善人类健康问题为己任，努力做出高质量、价格低、疗效好和安全性高的药品，创造制药企业的社会价值，实现制药人的人生价值。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>他山之石—政策引导的仿制药变革 （美国篇）</title>
    <updated>2020-10-23T09:10:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/oM16Rq0hmTpmsmnPdWzzTQ</id>
    <link href="https://mp.weixin.qq.com/s/oM16Rq0hmTpmsmnPdWzzTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《化学仿制药口服片剂功能性刻痕设计和研究技术指导原则（试行）》</title>
    <updated>2020-10-23T09:10:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/CuQ_suJeAF8-XA6AX01Dtg</id>
    <link href="https://mp.weixin.qq.com/s/CuQ_suJeAF8-XA6AX01Dtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《盐酸多柔比星脂质体注射液仿制药研究技术指导原则》和《注射用紫杉醇（白蛋白结合型）仿制药研究技术指导原则》</title>
    <updated>2020-10-23T09:10:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/MrcMDbkyTJhryW_O5BRynw</id>
    <link href="https://mp.weixin.qq.com/s/MrcMDbkyTJhryW_O5BRynw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《中药注册受理审查指南（试行）》</title>
    <updated>2020-10-23T09:10:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/5VggBHqbpzLQHHN9Ynz2Aw</id>
    <link href="https://mp.weixin.qq.com/s/5VggBHqbpzLQHHN9Ynz2Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吸入制剂开展生物等效性试验思路（二）</title>
    <updated>2020-10-19T09:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/a3OPG6LHZMrsKdYNkMfFGA</id>
    <link href="https://mp.weixin.qq.com/s/a3OPG6LHZMrsKdYNkMfFGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《境外已上市境内未上市药品临床技术要求》</title>
    <updated>2020-10-19T09:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/r0NK7xkWs4elQw4PnPyMxA</id>
    <link href="https://mp.weixin.qq.com/s/r0NK7xkWs4elQw4PnPyMxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《经口吸入制剂仿制药药学和人体生物等效性研究指导原则（征求意见稿）》</title>
    <updated>2020-10-19T09:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/EbWCjh6-DNOBNQe6O931yQ</id>
    <link href="https://mp.weixin.qq.com/s/EbWCjh6-DNOBNQe6O931yQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一种药物“新”剂型--口服&#34;果冻&#34;制剂的简介</title>
    <updated>2020-10-09T09:29:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-09:/s/rZ_oOaLIJ4LrRj85kUqxPw</id>
    <link href="https://mp.weixin.qq.com/s/rZ_oOaLIJ4LrRj85kUqxPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十一小长假，健康不打烊！这份假期健康指南请收下！</title>
    <updated>2020-10-01T07:44:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-01:/s/y_v-59xOz4eGfj7WmfTzaw</id>
    <link href="https://mp.weixin.qq.com/s/y_v-59xOz4eGfj7WmfTzaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何成为一名合格的稽查员？</title>
    <updated>2020-09-23T14:10:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-23:/s/82KmsHHxH7ye_P4ApZ-nOg</id>
    <link href="https://mp.weixin.qq.com/s/82KmsHHxH7ye_P4ApZ-nOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第三次国家药品集采后的思考</title>
    <updated>2020-09-18T15:50:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-18:/s/mMkeMUgSdAYOw7vSUELh6Q</id>
    <link href="https://mp.weixin.qq.com/s/mMkeMUgSdAYOw7vSUELh6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅谈如何做好药品研发质量管理体系</title>
    <updated>2020-09-07T11:38:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-07:/s/1MDIL1Q6dHq69U6aI49jwA</id>
    <link href="https://mp.weixin.qq.com/s/1MDIL1Q6dHq69U6aI49jwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>特殊注射剂药学技术探讨系列之一混悬型注射剂</title>
    <updated>2020-09-01T16:45:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-01:/s/iPwwWRsI8Qyziytom4Si0A</id>
    <link href="https://mp.weixin.qq.com/s/iPwwWRsI8Qyziytom4Si0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>研究中心筛选访视（一）前期准备</title>
    <updated>2020-08-26T12:49:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-26:/s/mFsbzjyypoNlAc3wnY0wUQ</id>
    <link href="https://mp.weixin.qq.com/s/mFsbzjyypoNlAc3wnY0wUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗肿瘤药物临床数据审评思路分析（二）</title>
    <updated>2020-08-19T11:42:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-19:/s/iJ-eWTvLEA8x-QJI2s-b6A</id>
    <link href="https://mp.weixin.qq.com/s/iJ-eWTvLEA8x-QJI2s-b6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>